At the time of writing, shares in the cannabis healthcare company are trading 5.3% higher at 49.5 cents.
What’s driving the Bod share price higher?
The company has delivered record sales for the second-quarter of the 2021 financial year.
For the period ending December 31, total attributable sales came in at $3.3 million. This represents a 52% lift on the previous quarter, and 144% increase over the same time last year.
The strong performance was underpinned by a number of purchase orders from Bod’s exclusive global partner, Health & Happiness. The latter recently launched CBD and hemp products across European markets such as the Netherlands, France, Italy, and the United Kingdom.
In addition, Bod revealed that an uptick in prescription volumes of its medicinal cannabis product, MediCabilis, contributed to the sound result.
In addition, the company says that both its cannabis medical division and CBD and Hemp consumer products are generating strong recurring revenue.
Bod further noted that sales growth is expected to continue in the current quarter and foreseeable future. This is backed by the company strategically entering new attractive markets while focusing on growth in Australian and United Kingdom medicinal cannabis sales.
Comments from the CEO
Bod CEO Jo Patterson, hailed the milestone, saying:
The progress achieved over the last quarter is a great result for Bod. The company has considerably broadened its international footprint, with new market entries into the Netherlands, France and Italy, as well as extended its product ranges in the UK. Further, we have increased sales of our medicinal cannabis products in Australia and are now benefitting from this growth.
Demand for our medicinal cannabis, and CBD and hemp products continues to escalate and we expect binding purchase orders to increase during the current period and the remainder of FY2021. Bod has also retained a strong cash balance, which will allow it to progress a number of initiatives including new market entries and product launches. We look forward to updating shareholders on progress over the coming months.
About the Bod share price
The Bod share price has gained 312% over its multi-year low of 12 cents reached in March last year, outperforming the All Ordinaries Index (ASX: XAO) in the same time frame.
Shares in the company hit an all-time high of 74 cents at the start of December.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of February 15th 2021
Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
- The Santos (ASX:STO) share price dips on stable credit rating – February 26, 2021 5:13pm
- Pentanet (ASX:5GG) share price falls despite strong gaming interest – February 26, 2021 4:10pm
- iCar Asia (ASX:ICQ) share price stalls on sliding revenue – February 26, 2021 3:09pm